UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042088
Receipt number R000046157
Scientific Title Inherited Bone Marrow Failure Syndrome Registry
Date of disclosure of the study information 2021/01/01
Last modified on 2020/10/12 17:37:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Inherited Bone Marrow Failure Syndrome Registry

Acronym

IBMFS Registry

Scientific Title

Inherited Bone Marrow Failure Syndrome Registry

Scientific Title:Acronym

IBMFS Registry

Region

Japan


Condition

Condition

Inherited bone marrow failure syndrome

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To study the clinical course and clinical feature of inherited bone marrow failure syndrome.

Basic objectives2

Others

Basic objectives -Others

To investigate the effect and safety profile of therapeutic agents administered for inherited bone marrow failure syndrome.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

none

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with inherited bone marrow failure syndrome.

Key exclusion criteria

Those who judged to be ineligibility in the study by researchers.

Target sample size

9999


Research contact person

Name of lead principal investigator

1st name Etsuro
Middle name
Last name Ito

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Community Medicine

Zip code

036-8562

Address

5 Zaifu-cho, Hirosaki, Aomori, Japan

TEL

0172-39-5070

Email

eturou@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name Kiminori
Middle name
Last name Terui

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Pediatrics

Zip code

036-8562

Address

5 Zaifu-cho, Hirosaki, Aomori, Japan

TEL

0172-39-5070

Homepage URL


Email

teru@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labor and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学医学部附属病院(青森県)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 01 Month 01 Day

Date of IRB

2020 Year 10 Month 01 Day

Anticipated trial start date

2021 Year 01 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study intends to collect medical information on inherited bone marrow failure syndrome patients and build a patient registry.


Management information

Registered date

2020 Year 10 Month 12 Day

Last modified on

2020 Year 10 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046157


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name